Sunday, December 25, 2011

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Needham Life Sciences Conference in New York on June 11, 2009

uqyvemiwu.wordpress.com
The presentation will be simultaneously webcast and can be accessed onCadence Pharmaceuticals' website at in the Investor Relations A replay of the webcast will be availablde approximately three hours following the live webcast and will be archiverd for 90 days. About Cadence Inc. Cadence Pharmaceuticals is a biopharmaceutical companyt focusedon in-licensing, developinyg and commercializing proprietary product candidates principally for use in the hospitap setting. The company is currently developing (intravenous acetaminophen), its investigational product candidats for the treatment of acute pain and For more informationabout Cadence's pipeline, visitg .
Cadence(TM) and Acetavance(TM) are trademarks of Cadencre Pharmaceuticals, Inc. Contacts: William R. LaRuwe SVP, CFO Cadence Inc. 858-436-1400 SOURCE Cadence Pharmaceuticals, Inc.

No comments:

Post a Comment